Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre …

R Carbonell, S Urgelés, A Rodríguez… - The Lancet Regional …, 2021 - thelancet.com
Background It is unclear whether the changes in critical care throughout the pandemic have
improved the outcomes in coronavirus disease 2019 (COVID-19) patients admitted to the …

Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real

LB Laguna, P Marcos-Neira, IM de Lagrán Zurbano… - Clinical nutrition, 2022 - Elsevier
Background & aims Dysphagia can be a consequence of prolonged hospitalization in
intensive care units (ICUs) due to severe SARS-CoV-2 pneumonia. This study aims at …

[PDF][PDF] A comprehensive review on navigating the neurological landscape of COVID-19: insights into etiopathogenesis and clinical management

R Chavhan, A Wanjari, S Kumar, S Acharya, N Rathod… - Cureus, 2024 - cureus.com
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has emerged as a global health crisis with significant …

The use of complementary and traditional medicine for the treatment of patients with COVID-19: A systematic review

B Badanta, MA Garcia, AE Jimenez, G Lucchetti… - Explore, 2023 - Elsevier
Objective The aim of this study was to evaluate the use and effectiveness of non-
pharmacological therapies as part of the treatment of COVID-19 and its complications, either …

Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study

Á Estella, JLG Garmendia, C De La Fuente… - Medicina Intensiva …, 2022 - Elsevier
Objective The objective of the study is to identify the risk factors associated with mortality at
six weeks, especially by analyzing the role of antivirals and munomodulators. Design …

Recomendaciones para el manejo de los pacientes críticos con COVID-19 en las Unidades de Cuidados Intensivos

P Vidal-Cortés, ED Santos, EA Alonso, RA Menéndez… - Medicina intensiva, 2022 - Elsevier
La pandemia por COVID-19 ha provocado el ingreso de un elevado número de pacientes
en UCI, generalmente por insuficiencia respiratoria severa. Desde la aparición de los …

Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort …

G Moreno, R Carbonell, I Martin-Loeches… - Annals of Intensive …, 2021 - Springer
Background Some unanswered questions persist regarding the effectiveness of
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …

Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

P Vidal-Cortés, ED Santos, EA Alonso… - Medicina Intensiva …, 2022 - Elsevier
The COVID-19 pandemic has led to the admission of a high number of patients to the ICU,
generally due to severe respiratory failure. Since the appearance of the first cases of SARS …

[HTML][HTML] Effects of Oxiris® Therapy on Cytokine Elimination after a LPS Infusion—An Experimental Animal Study

A Kalenka, P Arens, RM Müllenbach… - International Journal of …, 2024 - mdpi.com
The clinical effectiveness of Oxiris®, particularly in reducing cytokines, remains uncertain
due to the limited data provided. This study explored and analyzed the application value of …

Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review

D Andaluz-Ojeda, P Vidal-Cortes… - World Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic …